Reply to IL-18 is not therapeutic for neovascular age-related macular degeneration
Nat Med
.
2014 Dec;20(12):1376-7.
doi: 10.1038/nm.3741.
Authors
Sarah L Doyle
1
,
Peter Adamson
2
,
Francisco J López
3
,
Peter Humphries
4
,
Matthew Campbell
4
Affiliations
1
Department of Clinical Medicine, School of Medicine, Trinity College Dublin, Dublin, Ireland.
2
Ophthiris Discovery Performance Unit, GSK, Stevenage, UK.
3
Ophthalmology IPE US, RD Alternative Discovery and Development, GSK, King of Prussia, Pennsylvania, USA.
4
Ocular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
PMID:
25473915
DOI:
10.1038/nm.3741
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Choroidal Neovascularization / drug therapy*
Choroidal Neovascularization / prevention & control*
Humans
Interleukin-18 / therapeutic use*
Macular Degeneration / drug therapy*
Substances
Interleukin-18